Next Article in Journal
Antimalarial Activity of Tri- and Tetra-Substituted Anilino Pyrazoles
Next Article in Special Issue
Comparative Study of Molecular Descriptors of Pent-Heptagonal Nanostructures Using Neighborhood M-Polynomial Approach
Previous Article in Journal
Design, Physical Characterizations, and Biocompatibility of Cationic Solid Lipid Nanoparticles in HCT-116 and 16-HBE Cells: A Preliminary Study
Previous Article in Special Issue
Molecular-Composition Analysis of Glass Chemical Composition Based on Time-Series and Clustering Methods
 
 
Review
Peer-Review Record

Flavonoid Components, Distribution, and Biological Activities in Taxus: A review

Molecules 2023, 28(4), 1713; https://doi.org/10.3390/molecules28041713
by Qiang Wei *, Qi-Zhao Li and Rui-Lin Wang
Reviewer 1:
Reviewer 2:
Reviewer 3:
Molecules 2023, 28(4), 1713; https://doi.org/10.3390/molecules28041713
Submission received: 8 January 2023 / Revised: 29 January 2023 / Accepted: 2 February 2023 / Published: 10 February 2023
(This article belongs to the Special Issue Study of Molecules in the Light of Spectral Graph Theory)

Round 1

Reviewer 1 Report

Manuscript ID: molecules-2179780

Type of manuscript: Review

Title: Flavonoids Components, Distribution and Biological Activities in Taxus:A review

Authors: Qiang Wei *, Zhao Qi Li, Lin Rui Wang Submitted to section:

Computational and Theoretical Chemistry,

Journal: Molecules

 

The manuscript can be accepted after correcting the following mistakes.

 

1.       Lines 8 and 9: Taxol and Docetaxel proper names are capitalized - to be corrected

2.      Line 31-32: What is A, B C?  Draw a general formula or mark on Fig. 1

3.      Line 42 and 53:  backbone replaced with a skeleton

4.      Figure 1 lack of glycosides (line 38 …as seen in Figure 1)

5.      Line 48:…. distinct name from flavonols (with” a” )? - explain or give the name

6.      Line 49-52: obvious school knowledge why write this

7.      Line 55-58: is this the aim of the work?

8.      Line 62: species should be listed

9.      Line 62 .. genus….add the name

10.   Table 1. Molecular weight has more exact values (e.g. 270.24) and units. In table -No compounds, Name of compounds, parts of what? Maybe add a pharmacological activity?

11.  Improve Table 1 graphically in general

12.  No description under Table 1 to Figure 2. What is there and why etc?

13.  Figure 2 put in order : 3-6…  R1,R3,R4=H, R2=H etc (for all structures)

14.  Figure 2 compound 23 error R3=OH. This should be corrected

15.  Section 2.2 line 91: divide (1), (2), (3) with a space in the text marking the manuscript. The same is in chapter 3.

16.  Line 205: positive effects …… it should be corrected

17.  Line 209- 210: Kiessler ?, Berk.Curt?.....

18.  Line: 215-219

19.  description of research chaotic. List which 4 compounds. How were they studied (who studied them)? What were the reference drugs?

20.  Line 247: in vivo- italics

21.  Section 4.5 lacks reference drugs used in the study

22.  Section 4.6 should be a subsection of section 4.5

23.  Line 277: five biflavones … as bilobetin 3 insert compound numbers

24.  throughout the text, remove parentheses next to compound numbers (or throughout the manuscript, use them)

25.  Line 293-294: …and impovement of…- II separate sentence

26.  Lines 292-294 and 299-302 are about the same thing.

27.  Line 306-309:? The sentence makes no sense and should be corrected.

28.  References correct according to editorial guidelines

1-font

Missing pages 8,17,21,20,45,48,42

29.  Minor mistakes in language throughout the manuscript e.g:

Line28: other

Line 31 a C6-….

Line: 34,133,263,275,164,194…. –lack of the

Line 36: found in the plants

Line 52: flavans

Line 82: an additional

Line 83: compared

Line 136: falvanols

Line 115:  compounds

Line 161 in Table

Line 292: the biological activities…

etc…

 

 

 

Author Response

Dear  Reviewer:

    Thank you for your revised suggestions, which gave me a chance to improve the manuscript quality. I am so sorry for a little late reply to the revised manuscript. The details can be seen in the attachment. Thanks a lot.

Reviewer 1

The manuscript can be accepted after correcting the following mistakes.

  1. Lines 8 and 9: Taxol and Docetaxel proper names are capitalized - to be corrected

    Answer: It was corrected in the abstract.

  1. Line 31-32: What is A, B C?  Draw a general formula or mark on Fig. 1

    Answer: It was corrected on Fig. 1.

  1. Line 42 and 53:  backbone replaced with a skeleton

Answer: It was corrected.

  1. Figure 1 lack of glycosides (line 38 …as seen in Figure 1)

Answer: To keep the accordance with the words. Line 38 ....delete the "the glycosides"

  1. Line 48:…. distinct name from flavonols (with” a” )? - explain or give the name

Answer: explain as follows: They have a distinct name from flavanols (flavonols' first "o" is replaced)

  1. Line 49-52: obvious school knowledge why write this

Answer: It is simplified now.

  1. Line 55-58: is this the aim of the work?

Answer: It was corrected

  1. Line 62: species should be listed

Answer: It was corrected.

  1. Line 62 .. genus….add the name

Answer: It was corrected.

  1. Table 1. Molecular weight has more exact values (e.g. 270.24) and units. In table -No compounds, Name of compounds, parts of what? Maybe add a pharmacological activity?

Answer: It was corrected.

  1. Improve Table 1 graphically in general

Answer: It was corrected.

  1. No description under Table 1 to Figure 2. What is there and why etc?

Answer: They are explained separately in 3.1. Chemical Constituents and 3.2.Flavonoid distribution 5. Flavonoids's ioactivities

 

  1. Figure 2 put in order : 3-6…  R1,R3,R4=H, R2=H etc (for all structures)

Answer: It was corrected.

  1. Figure 2 compound 23 error R3=OH. This should be corrected

Answer: It was corrected.

  1. Section 2.2 line 91: divide (1), (2), (3) with a space in the text marking the manuscript. The same is in chapter 3.

Answer: It was corrected.

  1. Line 205: positive effects …… it should be corrected

Answer: It was corrected.

  1. Line 209- 210: Kiessler ?, Berk.Curt?.....

Answer: It was corrected.

  1. Line: 215-219

Answer: It was corrected.

  1. description of research chaotic. List which 4 compounds. How were they studied (who studied them)? What were the reference drugs?

Answer: It was corrected.

  1. Line 247: in vivo- italics

Answer: It was corrected.

  1. Section 4.5 lacks reference drugs used in the study

Answer: It was corrected.

  1. Section 4.6 should be a subsection of section 4.5

Answer: It was corrected.

  1. Line 277: five biflavones … as bilobetin 3 insert compound numbers

Answer: It was corrected.

  1. throughout the text, remove parentheses next to compound numbers (or throughout the manuscript, use them)

Answer: It was corrected.

  1. Line 293-294: …and impovement of…- II separate sentence

Answer: It was corrected.

  1. Lines 292-294 and 299-302 are about the same thing.

Answer: It was corrected.

  1. Line 306-309:? The sentence makes no sense and should be corrected.

Answer: It was corrected.

  1. References correct according to editorial guidelines

1-font

Missing pages 8,17,21,20,45,48,42

Answer: It was corrected.

  1. Minor mistakes in language throughout the manuscript e.g:

Line28: other

Line 31 a C6-….

Line: 34,133,263,275,164,194…. –lack of the

Line 36: found in the plants

Line 52: flavans

Line 82: an additional

Line 83: compared

Line 136: falvanols

Line 115:  compounds

Line 161 in Table

Line 292: the biological activities…

etc…

Answer: It was corrected.   

Author Response File: Author Response.docx

Reviewer 2 Report

The subject of the manuscript is interesting but requires substantial improvements before publication. The Introduction section must be modified. There are no references to the purpose and novelty of this review. I suggest the introduction of a section related to the physico-chemical properties of flavonoids, maybe even methods of extraction, and isolation. The section on the biological activity of Taxus flavonoids should be significantly improved. In my opinion, a presentation of the biological activity/therapeutic action of each type of flavonoid compound would be useful. The Conclusions section should be revised.

Author Response

Dear Reviewer:

    Thank you for your revised suggestions, which gave me a chance to improve the manuscript quality. I am so sorry for a little late reply to the revised manuscript. The details can be seen in the attachment. Thanks a lot.

Reviewer 2

The subject of the manuscript is interesting but requires substantial improvements before publication. The Introduction section must be modified. There are no references to the purpose and novelty of this review. I suggest the introduction of a section related to the physico-chemical properties of flavonoids, maybe even methods of extraction, and isolation. The section on the biological activity of Taxus flavonoids should be significantly improved. In my opinion, a presentation of the biological activity/therapeutic action of each type of flavonoid compound would be useful. The Conclusions section should be revised.

Answer:

1.physico-chemical properties , methods of extraction, and isolation has been added as seen 3.2 Flavonoid Properties, Extraction and Isolation

  1. In Table1, biological activities was added.
  2. The Introduction has added the purpose and novelty. " Nowadays, high and positive attention for health care has been focused on flavonoids. An European nutritional investigation proved that cancer had a direct relevance to flavonoids intake inpeople of different ethnicities[4]. Meanwhile, computer-aided workflows were used to design the drug based on flavonoid structures for better synthesis path, bioactive effects, and few side effects to the human body[5]"

Author Response File: Author Response.docx

Reviewer 3 Report

1/ There is a recently published book

Kumara Swamy, M., T. Pullaiah and Zhe-Sheng Chen. 2022. Paclitaxel: Sources, Chemistry, anticancer actions and Current Biotechnology. Elsevier.

This reference has not been quoted or cited anywhere in the paper. 

2.Species name first letter should be small letter. Many names in references are in capital letter (upper cap). Please change them to lower cap (small letters)

Comments for author File: Comments.pdf

Author Response

Dear Reviewer:

    Thank you for your revised suggestions, which gave me a chance to improve the manuscript quality. I am so sorry for a little late reply to the revised manuscript. The details is can be seen in the attachment. Thanks a lot.

1/ There is a recently published book

Kumara Swamy, M., T. Pullaiah and Zhe-Sheng Chen. 2022. Paclitaxel: Sources, Chemistry, anticancer actions and Current Biotechnology. Elsevier.

This reference has not been quoted or cited anywhere in the paper. 

Answer: This reference was added as reference 2.

2.Species name first letter should be small letter. Many names in references are in capital letter (upper cap). Please change them to lower cap (small letters)

Answer: It was corrected

Additionally, PDF part of the reviewer 3 was also corrected.

 

 

Other correction

1.English was edited through the correction of MDPI_english.

2.During the course of correction, there was some mistakes, so they are corrected simultaneously.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

Agree with the revision form of the manuscript.

Back to TopTop